切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2009, Vol. 03 ›› Issue (03) : 252 -254. doi: 10.3877/cma.j.issn.1674-0793.2009.03.024

循证医学

胰腺癌治疗的循证医学
余壮明1, 孙早喜1   
  1. 1.570102 海口,海南医学院临床学院外科
  • 收稿日期:2008-10-27 出版日期:2009-06-01

Zhuangming Yu, Zaoxi Sun   

  • Received:2008-10-27 Published:2009-06-01
引用本文:

余壮明, 孙早喜. 胰腺癌治疗的循证医学[J]. 中华普通外科学文献(电子版), 2009, 03(03): 252-254.

Zhuangming Yu, Zaoxi Sun. [J]. Chinese Archives of General Surgery(Electronic Edition), 2009, 03(03): 252-254.

1
赵玉沛.努力构建我国胰腺癌综合治疗多中心研究的技术平台.中华外科杂志,2007,45(1):1-2.
2
Stojadinovic A,Brooks A,Hoos A,et al.An evidence-based approach to the surgical management of respectable pancreatic adenocarcinoma.J Am Coll Surg,2003,196(6):954-964.
3
陆永奎.循证医学与肿瘤的综合治疗.广西医科大学学报,2006,23(9):66-67.
4
张延龄.胰腺癌综合治疗要坚持循证医学的原则.中国实用外科杂志,2004,24(5):257-258.
5
王立芳,徐振晔.中医药治疗恶性肿瘤与循证医学.中医药学刊,2005,23(9):1642-1643.
6
Rosen M,Ponsky J.Minimally invasive surgery.Endoscopy,2001,33(4):358.
7
Montori A.Minimally invasive surgery.Endoscopy,1999,31(1):110.
8
Mabrut J Y, Fernandez-Cruz L, Azagra J S, et al. Laparoscopic pancreatic resection: results of a multicenter European study of 127 patients. Surgery 2005,137(6):597-605.
9
Malaise J,Steurer W,Koenigsrainer A,et al.Simultaneous pancreas-kidney transplantation in a large multicenter study:surgical complications.Transplant Proc,2005,37(6):2859-2860.
10
Malaise J, Arbogast H, Illner WD, et al. Simultaneous pancreas-kidney trans-plantation: analysis of rejection.Transplant Proc, 2005, 37 (6):2856-2858.
11
Malaise J,Saudek F,Boucek P,et al.Tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation:the EURO-SPK 32 year results.Transplant Proc,2005,37(6):2843-2845.
12
詹文华.循证医学有望解决普通外科的争议性问题.中国实用外科杂志,2004,24(1):11-12.
13
张延龄.循证医学与外科临床经验总结.国外医学外科学分册,2001,28(6):321-323
14
Stojadinovic A,Hoos A,Brennan MF,et al.Randomized clinical trials in pancreatic cancer.Surg Oncol Clin N Am,2002,11(1):207-229.
15
Sasaki T,Maeda Y,Kobayashi T,et al.Standard chemotherapy for gastrointestinal malignancies based on evidence.Gan To Kagaku Ryoho,2000,27(2):166-176.
16
Yamaguchi K, Watanabe M, Nakamura M, et al. Japanese guidelines for treatment of pancreatic cancer based on evidence-based medicine. Nippon Rinsho,2006,64 Suppl 1:180-185.
17
Katz MH, Savides TJ, Moossa AR, et al. An evidence-based approach to the diagnosis and staging of pancreatic cancer. Pancreatology, 2005, 5(6):576-590.
18
HommaH,DoiT,Mezawa S,et al.Anovalarterialinfusion chemotherapy for the treatment of patients with advanced pancreatic cancer after vascular supply distribution via supers elective embolization.Cancer,2000,89(2):303-313.
19
Klinkernbij JH,Jeckel J,Sahmoud T,et al.Adjuvant radio therapy and 5-flurouracil after curative resection of pancreas and periampullary cancer.Ann Surg,1999,230(6):776.
20
Lorenz M,Heinrich S,Staib-Sebler E,et al.Regional chemotherapy in the treatment of advanced pancreatic cancer is it relevent?Eur J Cancer, 2000,36(8):957-965.
21
Muchmore,Carter RD,Preslan JE,et al.Regional chemotherapy with hemofiltration:a rationale for a different treatment approach to advanced pancreatic cancer.Cancer,1996,78(3 Suppl):664-669.
22
Mitsutsuji M,Suzuki Y,Iwanaga Y,et al.An experimental study on the pharmacokinetics of 5-fluorouracil regional chemotherapy for pancreatic cancer.Ann Surg Oncol,2003,10(5):546-550.
23
孙早喜.胰腺癌树突状细胞免疫治疗.中国新药与临床杂志,2004,23(6):382.
25
孙早喜,孙诚谊,王福生.树突状细胞疫苗诱导免疫效应细胞对PC3 生长的抑制作用.中华实验外科杂志,2006,23(1):26-27.
26
陈志峰,刘少翔,侯俊.癌瘤概念的再认识与中医药治疗研究的思考.中西医结合杂志,1996,16(6):368-370.
No related articles found!
阅读次数
全文


摘要